Biography:
Erynn Wardwell is a Managing Director at Syneos Health Consulting, where she focuses on value and access strategies aimed at improving patient access to evidence‑based therapies. Her work centers on translating clinical and real‑world evidence into payer and reimbursement approaches that support equitable, sustainable access, particularly for chronic conditions with significant public health impact. She collaborates with biopharmaceutical and healthcare stakeholders to reduce systemic barriers to care and enable earlier, more appropriate treatment for patients.



Uncovering barriers to therapy adoption by patient GLP-1 use status: A cross-sectional analysis using an AI-enabled patient priority tool